Viemed Healthcare (NASDAQ:VMD) posted its quarterly earnings results on Monday. The company reported $0.04 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.03 by $0.01, Yahoo Finance reports.
Shares of VMD stock traded down $0.30 during midday trading on Tuesday, hitting $9.75. 6,573 shares of the company were exchanged, compared to its average volume of 212,964. The firm’s 50 day moving average price is $9.78 and its two-hundred day moving average price is $9.76. Viemed Healthcare has a 52 week low of $6.17 and a 52 week high of $11.98.
Several research analysts recently issued reports on VMD shares. Zacks Investment Research lowered shares of Viemed Healthcare from a “hold” rating to a “sell” rating in a research report on Saturday, March 6th. Royal Bank of Canada started coverage on shares of Viemed Healthcare in a report on Thursday, March 11th. They set an “outperform” rating and a $13.00 price objective for the company. Finally, TheStreet raised shares of Viemed Healthcare from a “c” rating to a “b+” rating in a research note on Monday, March 8th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $12.33.
Viemed Healthcare, Inc, through its subsidiaries, provides in-home durable medical equipment and post-acute respiratory healthcare services to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen therapy, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services.
Featured Article: Should You Consider an Index Fund?
Receive News & Ratings for Viemed Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viemed Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.